Peptide Research Evidence Map: From Mechanism Papers to Batch Documentation
A broad peptide research article reframed around evidence tiers, peptide characterization, delivery constraints, and why documentation matters more than hype.
Read moreResearch articles
Since 2019, ADRIA has built a research-use-only article archive covering peptide literature, analytical documentation, storage, laboratory workflow, and evidence limits. The archive is organized by topic so researchers can move from source review to COA, calculator, and catalogue context quickly.
A broad peptide research article reframed around evidence tiers, peptide characterization, delivery constraints, and why documentation matters more than hype.
Read more
A second DSIP article rebuilt around historical characterization papers, small sleep and withdrawal studies, and why modern claims should stay limited.
Read more
A careful Melanotan II article focused on melanocortin receptor biology, early pigmentation studies, appetite-pathway models, and safety boundaries.
Read more
A tighter Ipamorelin research note focused on early GH-secretagogue studies, pharmacokinetic modeling, and evidence boundaries.
Read more
A rebuilt Ipamorelin review that removes benefit language and focuses on receptor signaling, GH pulsatility, and research documentation.
Read more
A professional overview of peptide drug-development literature, focused on sequence design, delivery constraints, synthesis, and documentation.
Read more
A revised Melanotan II article focused on melanocortin receptor biology, pigment-model history, appetite signaling, and safety limits.
Read more
A compliance-safe CJC-1295 + DAC article focused on GHRH analog design, drug-affinity complex chemistry, GH pulsatility, and IGF-1 marker research.
Read more
A technical note on mannitol, lyophilized peptide formulation context, bulking agents, and why excipient documentation should be explicit.
Read moreResearch-use access
Adria Peptides products are supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law.